A Lancet Psychiatry study links GLP-1 receptor agonists to fewer AUD and SUD hospitalizations—but th...
GLP-1s Are Cutting My AUD Patients’ Hospitalizations. Trial Designers Need to Know Why.
A Lancet Psychiatry study links GLP-1 receptor agonists to fewer AUD and SUD hospitalizations—but the post-discontinuation signal demands a closer look...
Author: The Clinical Trial Vanguard
Read Original Article